Zentalis Pharmaceuticals, Inc. (ZNTL)
1.695
+0.02
(+0.89%)
USD |
NASDAQ |
Nov 13, 16:00
1.695
0.00 (0.00%)
After-Hours: 19:59
Zentalis Pharmaceuticals Total Assets (Quarterly) : 270.19M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 270.19M |
| June 30, 2026 | 215.33M |
| March 31, 2026 | 253.07M |
| December 31, 2025 | 288.97M |
| September 30, 2025 | 327.25M |
| June 30, 2025 | 351.71M |
| March 31, 2025 | 384.02M |
| December 31, 2024 | 430.34M |
| September 30, 2024 | 450.66M |
| June 30, 2024 | 491.68M |
| March 31, 2024 | 557.48M |
| December 31, 2023 | 562.03M |
| September 30, 2023 | 585.72M |
| June 30, 2023 | 621.44M |
| Date | Value |
|---|---|
| March 31, 2023 | 489.34M |
| December 31, 2022 | 553.46M |
| September 30, 2022 | 529.19M |
| June 30, 2022 | 567.86M |
| March 31, 2022 | 405.68M |
| December 31, 2021 | 472.02M |
| September 30, 2021 | 435.08M |
| June 30, 2021 | 283.96M |
| March 31, 2021 | 328.35M |
| December 31, 2020 | 366.19M |
| September 30, 2020 | 393.23M |
| June 30, 2020 | 257.22M |
| March 31, 2020 | 87.63M |
| December 31, 2019 | 88.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 251.48M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 65.31M |
| Shareholders Equity (Quarterly) | 204.89M |
| Debt to Equity Ratio | 0.1792 |
| Current Ratio | 7.331 |
| Net Debt Paydown Yield | 0.34% |